Get started
Amylyx Pharmaceuticals, Inc.AA

Amylyx Pharmaceuticals, Inc.

3.66USDR
−0.21−5.43%
At close at Mar 28, 22:34 GMT
USD
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals Options
Back

Net income of Amylyx Pharmaceuticals, Inc.

Annual data
2020
2021
2022
2023
2024
TTM
‪‪−330.00 M‬‬
‪‪−220.00 M‬‬
‪‪−110.00 M‬‬
‪0.00‬
‪‪110.00 M‬‬
Period
Value
Change
Change %
TTM
‪‪−301.74 M‬‬
‪0.00‬
‪0.00‬%
2024
‪‪−301.74 M‬‬
‪‪−351.01 M‬‬
‪−712.42‬%
2023
‪‪49.27 M‬‬
+‪‪247.65 M‬‬
—
2022
‪‪−198.38 M‬‬
‪‪−110.44 M‬‬
‪−125.60‬%
2021
‪‪−87.93 M‬‬
‪‪−45.65 M‬‬
‪−107.97‬%
2020
‪‪−42.28 M‬‬
‪‪−28.56 M‬‬
‪−208.25‬%
Quarterly data
Q1 '21
Q2 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−120.00 M‬‬
‪‪−80.00 M‬‬
‪‪−40.00 M‬‬
‪0.00‬
‪‪40.00 M‬‬
Period
Value
Change
Change %
Q4 '24
‪‪−37.55 M‬‬
+‪‪35.16 M‬‬
+‪48.36‬%
Q3 '24
‪‪−72.70 M‬‬
‪‪−4.00 K‬‬
‪−0.01‬%
Q2 '24
‪‪−72.70 M‬‬
+‪‪46.09 M‬‬
+‪38.80‬%
Q1 '24
‪‪−118.79 M‬‬
‪‪−123.52 M‬‬
‪‪−2.61 K‬‬%
Q4 '23
‪‪4.73 M‬‬
‪‪−16.16 M‬‬
‪−77.36‬%
Q3 '23
‪‪20.89 M‬‬
‪‪−1.18 M‬‬
‪−5.35‬%
Q2 '23
‪‪22.07 M‬‬
+‪‪20.50 M‬‬
+‪‪1.30 K‬‬%
Q1 '23
‪‪1.57 M‬‬
+‪‪44.28 M‬‬
—
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q2 '21
Q1 '21